The DYNC1LI2 antibody is a research tool designed to detect and study the cytoplasmic dynein 1 light intermediate chain 2 protein, a component of the dynein motor complex. Cytoplasmic dynein 1 is a multi-subunit molecular motor responsible for retrograde intracellular transport along microtubules, playing critical roles in mitosis, organelle positioning, vesicle trafficking, and neuronal function. The DYNC1LI2 subunit is part of the light intermediate chain family, which contributes to dynein’s structural stability, cargo binding specificity, and regulatory interactions with other cellular components.
Mutations or dysregulation of dynein subunits, including DYNC1LI2. have been linked to neurodevelopmental disorders, neurodegenerative diseases, and ciliary defects. Researchers use DYNC1LI2 antibodies in techniques like Western blotting, immunofluorescence, and immunoprecipitation to investigate protein expression, subcellular localization, and interactions in normal and diseased states. These studies help elucidate dynein’s role in cellular dynamics, disease mechanisms, and potential therapeutic targets. Commercial DYNC1LI2 antibodies are typically validated for specificity using knockout controls or siRNA knockdowns. However, performance may vary depending on experimental conditions, emphasizing the need for optimization in different applications.